Madison Park Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$614K Sell
512
-4
-0.8% -$4.09K 0.44% 35
2026
Q1
$474K Buy
516
+4
+0.8% +$4.05K 0.37% 35
2025
Q4
$550K Buy
512
+4
+0.8% +$3.83K 0.45% 33
2025
Q3
$387K Buy
508
+90
+22% +$67K 0.32% 39
2025
Q2
$326K Buy
418
+8
+2% +$6.22K 0.27% 43
2025
Q1
$339K Buy
410
+3
+0.7% +$2.5K 0.3% 41
2024
Q4
$314K Sell
407
-156
-28% -$129K 0.25% 47
2024
Q3
$499K Buy
563
+3
+0.5% +$2.7K 0.37% 38
2024
Q2
$507K Buy
560
+22
+4% +$17.6K 0.42% 37
2024
Q1
$418K Sell
538
-20
-4% -$14.2K 0.36% 40
2023
Q4
$325K Buy
+558
New +$326K 0.31% 44

Other funds holding LLY

Madison Park Capital Advisors's LLY Position: Q2 2026 in Review

Madison Park Capital Advisors reduced its Eli Lilly (LLY) stake by 0.78% in Q2 2026, selling an estimated $4.09K and leaving 512 shares worth $614K. The position accounts for 0.44% of the portfolio, ranked #35.

Madison Park Capital Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Madison Park Capital Advisors held 512 shares of Eli Lilly worth $614K as of Q2 2026.
  • Madison Park Capital Advisors sold 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.44% of Madison Park Capital Advisors's portfolio in Q2 2026, its #35 holding.
  • Madison Park Capital Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Madison Park Capital Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.